References
- BrunkhorstFMEpidemiology, economy and practice – results of the German study on prevalence by the competence network sepsis (SepNet)Anasthesiol Intensivmed Notfallmed Schmerzther2006411434416440262
- TrampuzAZimmerliWPathogenesis und therapie der sepsisSchweiz Med Forum200335811818
- VincentJLSerranoECDimoulaACurrent management of sepsis in critically ill adult patientsExpert Rev Anti Infect Ther20119784785621810056
- RhodesAEvansLEAlhazzaniWSurviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016Intensive Care Med201743330437728101605
- SeymourCWLiuVXIwashynaTJAssessment of clinical criteria for sepsis: for the third international consensus definitions for sepsis and septic shock (Sepsis-3)JAMA2016315876277426903335
- Poli-de-FigueiredoLFGarridoAGNakagawaNSannomiyaPExperimental models of sepsis and their clinical relevanceShock200830Suppl 1535918704008
- RemickDGWardPAEvaluation of endotoxin models for the study of sepsisShock200524Suppl 171116374366
- Effenberger-NeidnichtKAl NatorMBrencherLOude LansinkMde GrootHPrevention of endotoxin-induced hypotension in rats by the circadian hormone melatoninInfection201341S11S12
- ZhaoBMoochhalaSMThamSYBiologically active components of Physostigma venenosumJ Chromatogr B Analyt Technol Biomed Life Sci20048121–2183192
- KalbAvon HaefenCSifringerMAcetylcholinesterase inhibitors reduce neuroinflammation and -degeneration in the cortex and hippocampus of a surgery stress rat modelPLoS One201385e6267923671623
- BettenDPVohraRBCookMDMatteucciMJClarkRFAntidote use in the critically ill poisoned patientJ Intensive Care Med200621525527716946442
- StilsonMKellyKSuchardJPhysostigmine as an antidoteCal J Emerg Med200124474820852697
- ZielmannSPetrowHWaltherPHenzeTIntensive care of delirium syndromesAnaesthesiol Reanim200328181212666506
- NilssonEMeretojaOANeuvonenPHemodynamic responses to physostigmine in patients with a drug overdoseAnesth Analg198362108858886614520
- PeterCSchmidtKHoferSEffects of physostigmine on microcirculatory alterations during experimental endotoxemiaShock201033440541120407407
- HoferSEisenbachCLukicIKPharmacologic cholinesterase inhibition improves survival in experimental sepsisCrit Care Med200836240440818091537
- ZhouJPavlovicDRübJPhysostigmine reverses disturbances of the intestinal microcirculation during experimental endotoxemiaClin Hemorheol Microcirc201456327328423736080
- ZunićGSavićJProstranMVaragićVVujnovSTodorovićZThe effect of physostigmine on acid-base status in arterial and venous blood of anaesthetized rabbits following hypovolemic shockGen Pharmacol19952622912957590076
- SavićJVaragićVMProkićDThe life-saving effect of physostigmine in haemorrhagic shockResuscitation199121157601852065
- GuariniSTagliaviniSFerrariWBertoliniAReversal of haemorrhagic shock in rats by cholinomimetic drugsBr J Pharmacol19899812182242804546
- MathisKWSulzerJMolinaPESystemic administration of a centrally acting acetylcholinesterase inhibitor improves outcome from hemorrhagic shock during acute alcohol intoxicationShock201034216216820023599
- Effenberger-NeidnichtKBrencherLBroecker-PreussMHamburgerTPetratFde GrootHImmune stimulation by exogenous melatonin during experimental endotoxemiaInflammation201437373874424385237
- PetratFSwobodaSde GrootHSchmitzKJQuantification of ischemia-reperfusion injury to the small intestine using a macroscopic scoreJ Invest Surg201023420821720690846
- VerhaeghRPetratFde GrootHAttenuation of intestinal ischemic injury and shock by physostigmineJ Surg Res2015194240541425483738
- ScreminOUScreminAMPhysostigmine induced reversal of ischemia following acute middle cerebral artery occlusion in the ratStroke1986175100410093764945
- KutsunaSTsurutaRFujitaMCholinergic agonist physostigmine suppresses excessive superoxide anion radical generation in blood, oxidative stress, early inflammation, and endothelial injury in rats with forebrain ischemia/reperfusionBrain Res2010131324224919968973
- ZimmermannJBPinderNBrucknerTAdjunctive use of physostigmine salicylate (Anticholium®) in perioperative sepsis and septic shock: study protocol for a randomized, double-blind, placebo-controlled, monocentric trial (Anticholium® per Se)Trials201718153029126416
- BernikTRFriedmanSGOchaniMCholinergic antiinflammatory pathway inhibition of tumor necrosis factor during ischemia reperfusionJ Vasc Surg20023661231123612469056
- PavlovVAWangHCzuraCJFriedmanSGTraceyKJThe cholinergic anti-inflammatory pathway: a missing link in neuroimmunomodulationMol Med200395–812513414571320
- TraceyKJPhysiology and immunology of the cholinergic antiinflammatory pathwayJ Clin Invest2007117228929617273548
- FodaleVSantamariaLBCholinesterase inhibitors improve survival in experimental sepsis: a new way to activate the cholinergic anti-inflammatory pathwayCrit Care Med200836262262318216614
- SulzerJKMolinaPEDelayed resuscitation with physostigmine increases end organ damage in alcohol intoxicated ratsShock2011351747920577152
- HoffmanJRMcelroyCRBicarbonate therapy for dysrhythmia and hypotension in tricyclic antidepressant overdoseWest J Med1981134160646259839
- EndouMTanitoYOkumuraFA comparison between chronotropic effects of neostigmine and edrophonium in isolated guinea pig right atriumJ Pharmacol Exp Ther19972823148014869316862
- SchultzJAHoffmanWEAlbrechtRFSympathetic stimulation with physostigmine worsens outcome from incomplete brain ischemia in ratsAnesthesiology19937911141218102038
- AkinciSBUluNYondemOZEffect of neostigmine on organ injury in murine endotoxemia: missing facts about the cholinergic antiinflammatory pathwayWorld J Surg200529111483148916222449
- SpitzerJJMyocardial metabolism during acute shock induced by hemorrhage, endotoxin, or physostigmine infusionMyocardial Metabolism19743161167